First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors https://t.co/oQYs9nUa3D
792 followers
792 followers
First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors. - PubMed - NCBI https://t.co/yxCuIQDI19
440 followers
RT @sitcancer: #JITC Research: First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients w…
19,289 followers
#JITC Research: First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors https://t.co/Xv9HJwN6jn https://t.co/jvqYo0Gutw